1. Home
  2. TTC vs PRAX Comparison

TTC vs PRAX Comparison

Compare TTC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$97.12

Market Cap

8.8B

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$280.25

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
PRAX
Founded
1914
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.3B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TTC
PRAX
Price
$97.12
$280.25
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$104.00
★ $572.13
AVG Volume (30 Days)
★ 818.2K
371.8K
Earning Date
06-04-2026
05-08-2026
Dividend Yield
★ 1.66%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.99
N/A
Revenue
★ $2,618,650,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$4.45
$7,758.26
P/E Ratio
$32.46
★ N/A
Revenue Growth
★ 4.53
N/A
52 Week Low
$67.64
$50.31
52 Week High
$105.19
$392.70

Technical Indicators

Market Signals
Indicator
TTC
PRAX
Relative Strength Index (RSI) 56.79 28.07
Support Level $96.15 $269.44
Resistance Level $101.14 $354.17
Average True Range (ATR) 1.96 14.59
MACD 0.50 -4.21
Stochastic Oscillator 83.00 6.95

Price Performance

Historical Comparison
TTC
PRAX

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: